Related Experiment Video
Updated: Jul 25, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
476
Interactome of Long Non-Coding RNAs: Transcriptomic Expression Patterns and Shaping Cancer Cell Phenotypes
Nicole R DeSouza1, Danielle Quaranto1, Michelle Carnazza1
1Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.
International Journal of Molecular Sciences
|June 28, 2023
Summary
Long non-coding RNAs (lncRNAs) are crucial in cancer development and progression. Aberrant lncRNA expression drives cellular transformation, offering new targets for cancer diagnostics and therapeutics.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- RNA biology has significantly advanced, revealing novel transcriptomic elements and functions.
- Cancer development involves mutations and genomic instability, but differential gene expression also drives carcinogenesis.
- Non-coding RNAs, especially long non-coding RNAs (lncRNAs), offer new insights into genomic and epigenomic regulation in cancer.
Purpose of the Study:
- To explore the role of differential gene expression patterns beyond mutations in cancer.
- To investigate the function of long non-coding RNAs (lncRNAs) in cellular activity and pathological transformation.
- To highlight the significance of lncRNA classification, structure, function, and therapeutic potential in cancer research.
Main Methods:
- Analysis of differential gene expression patterns in wild-type loci.
- Investigation of non-coding RNA roles in genomic and epigenomic regulation.
- Characterization of long non-coding RNA (lncRNA) expression and its correlation with cellular activity.
Main Results:
- Differential gene expression patterns in wild-type loci contribute to understanding cancer mechanisms.
- Aberrant long non-coding RNA (lncRNA) expression is correlated with pathological cellular transformation.
- lncRNA interactome analysis aids in defining cancer cell phenotype transcriptomic signatures.
Conclusions:
- Long non-coding RNAs (lncRNAs) play a critical role in governing cellular activity and driving cancer progression.
- Understanding lncRNA biology, including their classification, structure, and function, is vital for cancer studies and molecular targeting.
- lncRNA interactome studies enhance the definition of cancer-specific transcriptomic signatures for therapeutic development.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
01:20Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:18Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K